Podcasts about Reimbursement

The Myths of Biotech Investing Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Biotech investing differs from tech investing. There's often no revenue traction to assess. The startup must navigate the FDA path while dealing with cutting-edge devices and therapeutics. Here are some myths of biotech investing: Myth 1-Biotech startups are building companies. In many cases, the biotech startup will sell during the clinical trials or at FDA approval. They rarely proceed to launching a business. Myth 2- Biotechs take much longer than tech companies to exit. Most biotech startups exit in the 3 to 5 year range, which is often shorter than tech companies. Myth 3- Regulatory is the key hurdle to overcome. In reality, it's proving the therapeutic works. Most drugs fail in clinical trials and never reach FDA submission. Myth 4-Reimbursement is the key to a successful biotech therapy. In reality, it's showing value to the physician and patient through high efficacy and low toxicity, which is the key to success. Consider these myths in analyzing biotech startups for investment.   Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at:   Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

Jim and Chris discuss listener questions on surviving spouse Social Security benefits and Roth conversions, SSDI and pensions, the Social Security Fairness Act, managing large HSA reimbursements, and choosing between MYGAs and the TSP G Fund.(7:45) George asks whether Roth conversions count toward the earnings test when planning to claim his surviving spouse Social Security […] The post Social Security, HSA Reimbursements, and MYGAs: Q&A #2536 appeared first on The Retirement and IRA Show.

In this episode of Coffee with Samso, we sat down with Dustin Haines, the newly appointed CEO of Echo IQ Limited (ASX: EIQ), to unpack the company's transformative AI-based technology for cardiovascular diagnosis. While the format shifted to Zoom to accommodate Dustin's base in the United States, the conversation was no less in-depth as we explored how Echo IQ is aiming to solve one of the most pressing challenges in cardiovascular medicine—misdiagnosis.   With a 50% misdiagnosis rate in conditions like heart failure, Echo IQ's FDA-cleared AI solution could become a game-changer for structural heart disease diagnosis. This is a timely discussion as AI continues to gain traction in medical settings and investors begin to appreciate the real-world value of clinical validation and scalable software solutions. As always, grab your coffee and dive into the conversationo.   Chapters: 00:00 Start 00:10 introduction 01:47 Introducing Dustin Haines 05:42 The Cardiovascular Diagnosis Issue. 08:33 The milestones for EchoIQ Limited 13:45 What stage is EchoIQ at? 15:07 What is the core medical issue that EchoIQ is solving? 18:27 What is the accepted level of error for the EcoIQ product? 21:16 What is the realistic level of Misdiagnosis for EchoIQ? 23:58 Why is your technology good? 27:13 The EchoIQ WorkFlow Enhancement 30:06 The Revenue Pathway 33:32 Where does EchoIQ sit on the table of Market Leaders? 36:39 Reimbursement is the Key Revenue Driver. 37:46 Can EchoIQ technology be adopted to other pathways? 39:35 How far can AI go? 44:51 The Benefits and Issues of AI 46:57 Why buy EchoIQ shares? 49:54 What market capitalisation could investors of EchoIQ see in the future? 52:37 Dustin Haines' last Words 54:25 Conclusion

It's been nearly a year since the launch of the Indy Health District - an initiative that hopes to change those statistics. Indiana lawmakers this year tasked the Secretary of State's office with studying whether to require all counties to use vote centers. The Indiana Family and Social Services Administration is cutting voucher reimbursement rates for the Child Care and Development Fund. As the climate warms, armadillos are moving north — forcing communities to adjust to the unexpected newcomer. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

What happens when politics ignores kids? Pediatrician and South Carolina Senate hopeful Dr. Annie Andrews joins me to talk about why children's health depends on more than just doctor's visits - it depends on the policies shaping their lives. From Medicaid cuts to paid leave, gun safety, and the cost of insulin, Dr. Andrews explains why neutrality in medicine isn't an option and why pediatricians, and parents, have a responsibility to speak up. We discuss: Why Dr. Andrews made the leap from pediatrics to politics How policies like Medicaid cuts directly hurt children, families, and the health care system Why pediatricians and parents need to get louder in advocacy How healthcare has become political and why we need to be louder for our kids' future  The child tax credit and other policies that could transform children's futures How better policy can prevent burnout among doctors and improve care for every family To connect with Dr. Annie Andrews follow her on Instagram @annieandrewsmd, check out all her resources at https://drannieandrews.com/ We'd like to know who is listening! Please fill out our Listener Survey to help us improve the show and learn about you! 00:00 – Why Advocacy Alone Isn't Enough 01:11 – Politics Is Already in Our Lane 02:32 – Meet Dr. Annie Andrews: Pediatrician, Mom, Senate Hopeful 04:04 – From Clinic to Campaign: Why She Ran 07:06 – Kids Left Behind in Red vs. Blue States 09:30 – Why Staying Neutral Can Hurt Kids 12:22 – Advocacy vs. Politics: What Really Creates Change 15:26 – Looking Ahead: Policy Priorities if Elected 16:50 – Medicaid Cuts and What They Mean for Families 22:02 – How Cuts Affect Doctors, Patients, and the Whole System 25:14 – Burnout, Reimbursement, and a Broken System 28:15 – Why Pediatricians Must Step Into Politics 30:17 – Fixing the Workforce Crisis in Pediatrics 33:52 – Final Call to Action: Getting Loud for Kids 35:30 – How to Connect With Dr. Annie Andrews 38:21 – Closing Thoughts: Hope Through Action Our podcasts are also now on YouTube. If you prefer a video podcast with closed captioning, check us out there and ⁠subscribe to PedsDocTalk⁠. Get trusted pediatric advice, relatable parenting insights, and evidence-based tips delivered straight to your inbox—join thousands of parents who rely on the PDT newsletter to stay informed, supported, and confident. ⁠⁠⁠⁠Join the newsletter⁠⁠⁠⁠! And don't forget to follow ⁠⁠⁠⁠@pedsdoctalkpodcast⁠⁠⁠⁠ on Instagram—our new space just for parents looking for real talk and real support. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on the ⁠PedsDocTalk Podcast Sponsorships⁠ page of the website.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Margins are razor-thin on Amazon.Reimbursements are one of the easiest places to lose money. In this live session, Neil Twa and Lisa from GETIDA break down what reimbursements are, why they matter, and the major Amazon policy changes every seller needs to know.They cover how lost and damaged inventory impacts your bottom line, why new claim deadlines are shrinking from 18 months down to as little as 60 days, and how sellers can recover thousands in “found money” by auditing their accounts.In This Episode, We Cover:✅ The new Amazon rules cutting claim timelines from 18 months to 60 days✅ Why ignoring reimbursements is like handing free money to Amazon✅ Case studies: sellers recovering $40,000+ in reimbursements 

In this episode of Medsider Radio, we sat down with Christopher Haig, co-founder and CEO of Efemoral Medical. Efemoral is developing bioresorbable scaffold technology for peripheral arterial disease. Chris has over 25 years of experience in cardiovascular devices, holding leadership roles at strategics including Guidant Corporation and Abbott Vascular, and driving growth at startups such as Calypso Medical and QT Vascular, where he built commercial infrastructure and launched multiple products ahead of its $55 million IPO.In this interview, Chris shares how bioresorbable scaffold technology found new life for peripheral arterial disease — and the lessons on matching tech to significant needs and choosing trial sites for lasting data.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Christopher Haig.

Telehealth for speech therapy is under threat, and if Medicare pulls access, the consequences could ripple far beyond one program. Adults, families, and care partners lose critical care options, but that's just the start. A Medicare rollback could trigger private insurance and Medicaid to follow suit, resulting in reduced access across the board. In this episode, we explore why telehealth is crucial for patients who can't drive, for care partners balancing demanding schedules, and for clinicians serving rural and underserved communities. You'll also get advocacy tools, ready-to-use letter templates, and simple ways to mobilize your practice and patients to keep telehealth accessible.Find all of the advocacy tools you need here to participate in the telehealth call to action, or check out Katie's SLPs Blueprint to Medicare Success and get $100 off with the code FixSLP.Stop paying to track ASHA-approved CEUs. Save your money and set up for a FREE CEU/PDH tracker with Speech Therapy PD. While you are there, get $10 off a professional subscription with the code FixSLP10! Thank you to our sponsor, ⭐️ Befitting You Medical Supply ⭐️,  offering AAC devices with hands-on assessments, education, and support for patients and families. Check them out!New here? Subscribe, share with a colleague, and call the Minivan Meltdown line at fixslp.com to add your voice.

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of US Food and Drug Administration's COVID-19 vaccine indication changes and recission of the associated emergency use authorizations, as well as the postmarketing studies that now are required (:40), and their potential impact on access and reimbursement (12:20). More On These Topics From The Pink Sheet COVID-19 Vaccines: Pfizer Arguments To Keep EUA Failed To Persuade US FDA's Prasad: https://insights.citeline.com/pink-sheet/vaccines/covid-19-vaccines-pfizer-arguments-to-keep-eua-failed-to-persuade-us-fdas-prasad-V3X2OEBZE5HRHKO7KMMCFXBM2Q/ US FDA Updates COVID-19 Vaccine Formulations, Revokes EUAs, ACIP Use Decision Next: https://insights.citeline.com/pink-sheet/vaccines/us-fda-updates-covid-19-vaccine-formulations-revokes-euas-acip-use-decision-next-VBXJDSOA6BCOXNCA2TAH27EBJY/ A US FDA Move to Revoke Pfizer's Pediatric COVID-19 Vaccine EUA Could Raise Supply Questions: https://insights.citeline.com/pink-sheet/vaccines/a-us-fda-move-to-revoke-pfizers-pediatric-covid-19-vaccine-eua-could-raise-supply-questions-ZX26DBENHFCOHPBGMPFPQB6REQ/ Changes In Pediatric COVID-19 Vaccine Recommendations Causing Coverage Confusion: https://insights.citeline.com/pink-sheet/vaccines/changes-in-pediatric-covid-19-vaccine-recommendations-causing-coverage-confusion-WDEYUVJXGBCGBEVBQ2I6INH554/

In this episode of Medsider Radio, we sat down with Howard Rosen, co-Founder and CEO of Evident Vascular, a company developing an AI-powered intravascular ultrasound (IVUS) platform to improve vascular imaging and intervention. Before co-founding Evident, Howard held senior leadership roles at Intact Vascular and Vesper Medical, guiding both companies through successful acquisitions by Philips. He also served in executive roles at Haemonetics and BG Medicine, and spent over two decades at Boston Scientific, where he held a range of leadership positions across the peripheral and cardiovascular franchises.In this interview, Howard shares why launching right — not fast — is the key to success in medtech. He breaks down how Evident built early momentum by investing in deep market validation, engaging KOLs as true collaborators, and resisting scope creep at every turn. Howard also unpacks the company's deliberate regulatory strategy, using early FDA engagement as a tool to de-risk development. On the fundraising front, he explains why board composition matters more than valuation, and why strategic acquirers respond best to credibility, not cold outreach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Howard Rosen.

Join Kevin Cooley and Ashley Patil from Scout to explore how innovative technology is transforming the patient reimbursement process in clinical trials. They discuss the most common administrative challenges sites face, and how tools like the Scout Portal are easing the burden on site staff while improving the patient experience. From automated payments and travel coordination to real-time support and multilingual access, this episode highlights the power of combining tech and service. If your site is looking to save time, reduce friction, and improve retention, this conversation is for you.

Yukon Extends Nurse Signing Bonuses and Exam Fee ReimbursementThe Government of Yukon has extended nurse signing bonuses and exam fee reimbursement through to March 31, 2027, retroactive to April 1, 2025.In this episode, Joy Stephen, a Canadian Immigration practitioner, explains the bonus structure and eligibility:$7,500 signing bonus for new nurse practitioners and registered nurses$4,500 signing bonus for new licensed practical nursesExam fee reimbursement for new graduates joining Yukon government nursing positionsA 12-month service agreement is required for all bonusesThese incentives aim to attract and retain qualified nurses, strengthening healthcare delivery across Yukon communities.Previous Yukon updates: https://myar.me/tag/nt/Immigration program details: https://myar.me/cFree weekly resource & Q&A meetings: https://myar.me/zoomChoosing the right immigration representative: https://ircnews.ca/consultant#Yukon #NursesInCanada #CanadaImmigration #HealthcareCanada #IRCNews

Christophe Hennebelle, Vice president of corporate communications at Air Canada

https://dianacantureyna.substack.com/podcast https://www.cultivatingself.org/reclaiminghealthcarefellowship Our guest, Jayda Greco, is a partner at McDermott Will & Schulte, where she focuses on the intersection of healthcare and law. With a deep background in digital health, she's an expert in navigating the complex regulatory landscape, including privacy, compliance, and reimbursement. https://www.mwe.com/insights/food-as-medicine-a-deep-dive-into-reimbursement/ https://academic.oup.com/healthaffairsscholar/article/2/2/qxae013/7595880  

In this episode, Rodney Adams, SVP of Finance & Reimbursement for the Tennessee Hospital Association, discusses the intersection of healthcare finance.

In this episode of Medsider Radio, we sat down withTracy MacNeal, President and CEO of Materna Medical. Materna is developing two devices addressing different aspects of pelvic health: Ellora, aimed at preventing childbirth injuries during delivery, and Milli, designed to treat vaginismus, a pelvic floor condition that makes intercourse painful or impossible.Tracy is a healthcare executive and engineer with over 25 years of experience in medical devices, digital health, and women's health, including six successful transactions. In addition to heading Materna, Tracy serves on the AdvaMed Board and leads its Women's Health Equity Initiative, and was previously President of Diagnostics and Digital Health at Ximedica.In this interview, Tracy shares how clinical data enabled Materna to bridge B2B and B2C channels, and why clarity of focus is essential when commercialization paths diverge. Tracy also outlines what it takes to build in undefined markets, from aligning KOLs to publishing foundational definitions, and offers a candid perspective on what investors really want: clear financial returns, backed by a founder they trust to deliver when things go sideways.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tracy MacNeal.

Southwest Michigan's Afternoon News podcast is prepared and delivered by the WSJM Newsroom. For these stories and more, visit https://www.wsjm.com and follow us for updates on Facebook. See omnystudio.com/listener for privacy information.

Texas could receive a significant portion of a $13.5 billion federal reimbursement package aimed at border security. The funding, approved by Congress, will cover expenses incurred since January 20, 2021, the day President Biden took office.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Visit: RadioLawTalk.com for information & full episodes! Follow us on Facebook: bit.ly/RLTFacebook Follow us on Twitter: bit.ly/RLTTwitter Follow us on Instagram: bit.ly/RLTInstagram Subscribe to our YouTube channel: www.youtube.com/channel/UC3Owf1BEB-klmtD_92-uqzg Your Radio Law Talk hosts are exceptional attorneys and love what they do! They take breaks from their day jobs and make time for Radio Law Talk so that the rest of the country can enjoy the law like they do. Follow Radio Law Talk on Youtube, Facebook, Twitter & Instagram!

It's YOUR time to #EdUpStay ahead of the conversation in higher ed. Get early, ad-free access & exclusive leadership content by supporting Elvin & Joe for only $5.99 a month. YOU can also donate or gift a subscription at edupexperience.comIn this episode, YOUR guest is Robert Towner, Associate Vice President, EDGE - Northeastern UniversityYOUR host is ⁠⁠Dr. Joe Sallustio  How does Northeastern's Edge unit break away from traditional academic silos to create interdisciplinary programs? What makes performance based admissions a game changer for corporate partnerships in higher ed? How is Edge transforming tuition reimbursement from uncontrolled spending into strategic talent management? Topics include:B2B talent management partnerships vs traditional articulation agreements Stackable credentials & digital upskilling hubs Prior learning assessment for working professionals Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠● Join YOUR EdUp community at The EdUp ExperienceWe make education YOUR business!P.S. Support the podcast trusted by higher ed leaders. Get early, ad-free access & exclusive leadership content by supporting Elvin & Joe for only $5.99 a month. YOU can also donate or gift a subscription at edupexperience.com

In this episode of Medsider Radio, we sat down with Joanna Nathan, CEO and co-founder of Prana Surgical — a startup developing image-guided surgical platforms for precision oncology.  Joanna's career spans translational research at Texas Heart Institute, product development at Saranas, and portfolio management at Mercury Fund and Johnson & Johnson's Center for Device Innovation. She mentors founders through her not-for-profit organization Enventure and teaches entrepreneurship at Rice University's Jones School of Business.In this interview, Joanna shares her framework for evaluating which medtech ideas merit pursuit, revealing three critical signals every founder should look for: clinical urgency that requires no convincing, favorable asymmetry between value and technical risk, and optimal market timing. Joanna also demonstrates how systematic grant applications and strategic resource allocation can extend runway while building investor credibility, and addresses the unique psychological challenges of building life-critical devices.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Joanna Nathan.

If your employer offers tuition benefits, you may be able to advance your education at a lower cost — and without skipping a beat at work. So how does tuition reimbursement work? And what is tuition assistance, exactly? Staff at Southern New Hampshire University (SNHU) explain it all. They also discuss how you can find out if your employer offers tuition benefits — and what to do if they don't. Learn more about the often-overlooked employee benefit: https://www.snhu.edu/about-us/newsroom/education/what-is-tuition-reimbursement/?utm_source=YouTube&utm_medium=socialmedia&utm_campaign=YTchannel_Bitly&utm_content=how-tuition-reimbursement-works_SEP_SEP_38&snhu_segment=ol

In this episode, Christina Brown, BESLER's VP of Reimbursement Services, provides a look into BESLER's 2025 Reimbursement Symposium live on Wed., August 13, at Noon ET.

Dr Murali Ramachandra, CEO of Aurigene Oncology, talks to Anju Ghangurde about the tough biotech funding environment, promising pipeline assets including a CAR-T cell therapy in Phase II and ‘hybrid' manufacturing options, besides outcome-based reimbursement models. The promise of bispecifics and multispecifics in oncology, including Chinese biotech Akeso's PD-1/VEGF bispecific antibody, are some of the other topics he discussed.

An interview with Dr. Kathryn Schmitz, Interim Director of the UPMC Hillman Cancer Center.We have one randomized control trial showing, in one group of cancer patients, that there is a disease free survival benefit and a mortality benefit, and we know that there's a lot of nice to have outcomes, right? Nice, nice to have is quality of life, things that are not going to be something that the payer pays for. So there's our challenge, that's the truth, that's the truth of our situation. That's why it's going to be difficult. And I think the challenge provides us one of the first opportunities to be able to really lay all of that bare. And then the question becomes, how do we motivate hospitals, healthcare systems and payers to pay for something when there is no profit in it for them?Dr. Kathryn SchmitzEvidence for exercise as a standard of care in cancer treatmentImproving access to exercise oncology programsMaking the case for reimbursement for exercise oncology programsCMS coverage of supervised exercise training for people with cancerMoving Through Cancer areas of focusPrognosis for 2029https://www.movetolivemore.com/https://www.movetolivemore.com/bookhttps://www.linkedin.com/company/move-to-live-more@MovetoLiveMore

In this episode of Medsider Radio, we sat down with Greg Lipschitz, CEO of Firefly Neuroscience. Firefly's FDA-510(k) cleared Brain Network Analytics (BNA™) technology objectively measures brain function through EEG analysis. With a proprietary database spanning twelve cognitive disorders, the company serves both clinical practitioners and pharmaceutical partners.Greg brings extensive experience in private equity, investment banking, capital markets, and finance to his leadership role. As Managing Director of Old Stone Advisors and former Vice President of Lazer Capital, Greg has advised on over $1 billion in transactions. He is a Chartered Financial Analyst.In this interview, Greg shares insights on strategic fundraising approaches, platform prioritization decisions, and building commercial momentum in healthcare through direct sales and customer feedback loops.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Greg Lipschitz.

Do you know exactly how you're getting paid as a physician—or are you just cashing your paychecks and hoping your employer will keep paying you?Whether you're newly out of residency, launching your own practice, or working in a hospital system, understanding the payment models that fund your career is crucial. In this episode, Coach JPMD breaks down the fundamentals of physician compensation—from fee-for-service to capitation, hospital DRG payments, and the growing trend of membership-based models like direct primary care (DPC)Learn how each payment model impacts your income, flexibility, and long-term wealth potentialDiscover the hidden forces behind hospital salaries and how they really get reimbursedFind out why direct primary care could be the most empowering option for physicians looking to practice medicine their wayIf you want to finally take control of your earning power and understand where your money actually comes from, hit play on this episode now.TEXT HERE to suggest a future episode topic Discover how medical graduates, junior doctors, and young physicians can navigate residency training programs, surgical residency, and locum tenens to increase income, enjoy independent practice, decrease stress, achieve financial freedom, and retire early, while maintaining patient satisfaction and exploring physician side gigs to tackle medical school loans.

In this episode of Medsider Radio, we sat down with Maulik Nanavaty, CEO of Anumana. Anumana, an AI-driven health technology company focused on cardiovascular care, is taking a pragmatic approach to scaling AI in medicine.Maulik is a seasoned healthcare executive with over 30 years of global experience in the medical device industry. He spent 18 years at Boston Scientific, where he led its $1B+ Neuromodulation division and served as President of Boston Scientific Japan. Prior to that, he held leadership positions at Baxter. Known for driving innovation in implantable and artificial intelligence (AI)-powered technologies, Maulik also serves on the board of Rani Therapeutics.In this interview, Maulik shares why building a strong risk-benefit case and designing around real-world clinician needs are key to adoption. With data from over 20 million patients and a focus on transparency, Anumana is reshaping how AI reaches the point of care.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Maulik Nanavaty.

State lawmakers have overridden Gov. Greg Gianforte's veto of a bill that will pay county jails for holding inmates awaiting space at the state psychiatric hospital.

Precision medicine has long guided cancer treatment by matching therapies to tumor mutations, but the emerging field of predictive genomics aims to take this further by factoring in a patient's genetics, health history, and environment to better predict drug response. Ask ChatGPT

Robert is joined by Greg Rueter of R+R Insurance Advisors to talk about deductible reimbursement benefits. Rising premiums on homeowners and auto policies have consumers looking for relief. Products that offer deductible reimbursements could be an answer. Click here to view programs discussed on this episode. Enter "BMFCE" in the Producer ID field for a coupon worth $25 off your next CE webinar with BMFCE! BMFCE: Insurance producers and adjusters can earn insurance continuing education credit listening to Robert's live webinars. No test required for credit! BMFCE.com.

This episode is sponsored by: My Financial Coach You trained to save lives—who's helping you save your financial future? My Financial Coach connects physicians with CFP® Professionals who specialize in your complex needs. Whether it's crushing student loans, optimizing investments, or planning for retirement, you'll get a personalized strategy built around your goals. Save for a vacation home, fund your child's education, or prepare for life's surprises—with unbiased, advice-only planning through a flat monthly fee. No commissions. No conflicts. Just clarity. Visit: https://myfinancialcoach.com/bootstrapmd/ to meet your financial coach and find out if concierge planning is right for you. ________ Burnout is still sky-high. Reimbursements keep shrinking. In this solo episode, Dr. Mike Woo-Ming explores why more and more physicians are turning away from the traditional insurance-based model and instead embracing direct pay, concierge, aesthetics, telemedicine, and niche practices. He shares the data, real-world stories, and his own experience to help you understand the market shift and take advantage of it. This isn't just about frustration—it's about opportunity. Dr. Mike breaks down how to move forward strategically, even if you're not ready to quit your job just yet. From small side gigs to full-blown business transitions, this episode is your blueprint for practicing medicine on your terms. _____________  Three Actionable Takeaways: Recognize the problem hiding in plain sight. Burnout, shrinking margins, and prior auth fatigue are signals—not a dead end. Start simple. Test a part-time model, telemedicine, or aesthetics before fully transitioning out of insurance. Think like a CEO. Make the mental shift from being an employee to owning your value and building your business. About the Host: Dr. Mike Woo-Ming has over 20 years of experience as a physician entrepreneur. He's built and sold multiple seven-figure companies and now leads Executive Medical, a group of clinics specializing in age management and aesthetics. Through BootstrapMD, he mentors physicians in business, content creation, and autonomy.

President Trump signed the “One Big Beautiful Bill Act” into law on July 4 and now leaders such as Stephanie Carlton are in charge of implementing it. She's the deputy administrator and chief of staff at the Centers for Medicare & Medicaid Services. Carlton and the administration see the law's benefits because Medicaid reimbursement rates “were allowed to go up to commercial rates and states are at varying levels towards that cap. But as we sat back and looked at... Read More Read More The post Dr. Oz's Second-in-Command Explains Need for Medicaid Reimbursement Cuts as “Big Beautiful Bill” Passes appeared first on Healthy Communities Online.

In this episode of Medsider Radio, we had a fascinating chat with Mary Lou Jepsen, founder and Chairman of Openwater, a medtech company developing breakthrough diagnostic and therapeutic wearables for cancer, stroke, mental illness, and beyond. Openwater is rethinking how medical devices are built — not as single-purpose machines, but as flexible platforms that function more like smartphones. A physicist and prolific inventor, Mary Lou holds nearly 300 patents and has launched over 50 products across VR, AR, holography, and consumer electronics. Previously, she led engineering at Intel, Facebook, and Google, taught at MIT, and now serves on the boards of Lear Corporation and Luminar Technologies. She has been named to Time magazine's list of the 100 most influential people. In this interview, Mary Lou explains why the traditional “one disease, one device” model falls short, and how her team is applying consumer electronics and open-source principles to develop scalable, software-driven tools. Backed by renowned investors including Khosla Ventures, Vitalik Buterin, and Esther Dyson, Openwater is aiming to make advanced care more accessible worldwide.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Mary Lou Jepsen.

Welcome to the ABA Business Leaders News, the go-to show for aspiring and current ABA practice owners who want to keep up to date with the latest happenings in the world of ABA. Every week, your hosts April and Stephen Smith bring you actionable insights, news, and real-world advice to help you navigate the challenges and celebrate the wins of starting and running your own ABA practice.

In this episode, Craig Douglas, SVP of HME, Respiratory, & Wellness at VGM, is joined by Melanie Ewald, VP of Payer Relations and Reimbursement, and Kim Cuce', Director of Business Optimization, to tackle one of the biggest challenges in the HME industry: closed payer networks. They share practical strategies for navigating out-of-network situations, working with third-party administrators, and pursuing single case agreements, while emphasizing the importance of clear patient communication, understanding reimbursement, and knowing, understanding, and keeping copies of your contracts.

In episode #114, we get into the complex world of reimbursement in the California Workers' Compensation system. Whether you're an injured worker, the family of an injured worker or know someone that has been injured at work, it's essential to understand how the reimbursement  processes work. We break down what expenses are eligible for reimbursement and what you can submit for mileage reimbursement for travel to medical appointments. We also explore the ins and outs of medical provider reimbursements—from treatment approvals to payment delays and billing disputes. You'll learn: What you can add to a mileage reimbursement in CA workers' comp What qualifies as a reimbursable medical expense Tips for avoiding common mistakes that delay payment This episode provides clear and actionable insights to help you get the reimbursement you're entitled to.  

Send us a textIn this episode of the Private Practice Survival Guide, we discuss the single most impactful strategy for successfully negotiating higher insurance reimbursement rates—making a strong, data-driven ROI case. We break down how to quantify your value to insurance companies by tracking revenue generation, cost savings, and clinical outcomes. The episode also explores how to present your data effectively during negotiations, including tips for creating compelling visual aids and aligning your proposal with payer priorities. By mastering this approach, you can secure rate increases that significantly boost your practice's bottom line. Welcome to Private Practice Survival Guide Podcast hosted by Brandon Seigel! Brandon Seigel, President of Wellness Works Management Partners, is an internationally known private practice consultant with over fifteen years of executive leadership experience. Seigel's book "The Private Practice Survival Guide" takes private practice entrepreneurs on a journey to unlocking key strategies for surviving―and thriving―in today's business environment. Now Brandon Seigel goes beyond the book and brings the same great tips, tricks, and anecdotes to improve your private practice in this companion podcast. Get In Touch With MePodcast Website: https://www.privatepracticesurvivalguide.com/LinkedIn: https://www.linkedin.com/in/brandonseigel/Instagram: https://www.instagram.com/brandonseigel/https://wellnessworksmedicalbilling.com/Private Practice Survival Guide Book

In this episode of Medsider Radio, we sat down with Anthony Fernando, President and CEO of Asensus Surgical.Asensus is expanding the role of robotics in the OR with its performance-guided surgery platform — a digital-first, AI-enabled system designed to enhance precision and real-time decision-making. A mechanical engineer by training, Anthony has more than two decades of experience spanning medtech, robotics, and global operations. He joined Asensus in 2015 and previously served as Chief Operating Officer and Chief Technology Officer. Earlier in his career, Anthony held leadership roles at Stryker, Becton Dickinson, PerkinElmer, and Varian, where he focused on advancing automation and medical device innovation across international markets.In this interview, Anthony shares how the Durham, NC–based Asensus navigated uncharted regulatory territory for a first-of-its-kind technology and proactively made the case for acquisition — well before KARL STORZ came to the table.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Anthony Fernando.

This Week in Pharmacy – June 27, 2025 Episode Title: “Going on the Offensive to Protect Public Health”

June 27, 2025 Scott, Mark, and Ray discuss how new FDA rulings—like the recent update for Rezūm—impact coverage, coding, and reimbursement. They walk through the layers of medical necessity, CPT codes, payer policies, and documentation strategies needed to ensure payment.PRS Coding and Reimbursement HubAccess the Hub Free Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.https://www.prsnetwork.com/joinuptp Click Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of Medsider Radio, we had a really engaging conversation with James (Jim) Corbett, CEO of AVITA Medical.AVITA Medical's RECELL system uses Spray-On Skin Cell technology to accelerate healing for patients with severe burns and wounds.  Jim brings nearly 40 years of medical device leadership experience to AVITA Medical. His career spans global commercial and operational roles, including President of Boston Scientific and General Manager of Scimed Life Systems. Jim has served as CEO of six companies, including three publicly traded entities — Microtherapeutics, ev3, and Alphatec Spine — as well as CathWorks, Home Diagnostics, and Vertos Medical.In this interview, Jim shares lessons from a career spanning global medtech leadership positions — including the importance of hands-on fundraising, adapting sales strategies as products mature, and how generating clinical evidence beyond FDA requirements serves commercial adoption.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Jim Corbett.

In this episode, Erica Carbajal speaks with Kevin Isaacs, Founder and President of Tribunus Health, about the urgent need for more equitable behavioral health reimbursement. Kevin shares how personal experiences shaped his mission to help providers negotiate sustainable payer contracts. He also dives into the power of data, price transparency, and strategic partnerships to level the playing field for independent behavioral health organizations.This episode is sponsored by Tribunus Health.

In this episode, we getting a billing and coding update with Frontline favorite, Dr. Michael Granovsky. We also focus on how emergency physicians can utilize observation status and documentation to offset the lost opportunities of occupied beds in the ED.

Montana physical therapists are concerned that Medicaid reimbursement rates are not meeting even the cost of their care, and that a bipartisan bill was recently vetoed that would have made some key adjustments. Click on the podcast to hear from […] The post Physical Therapists Concerned Reimbursement Rates May Force Patient Exclusion, Clinic Closures first appeared on Voices of Montana.

Two years ago, Dr. Traci Hurley lost her husband, Dr. Dan Hurley, to cancer.  Dan spent the last few years of his life battling his disease - and his insurance company.  Before he died, he set himself a goal to, in his own words, help “with the problem of insurance company physicians without expertise denying or delaying care as recommended by the patient's chosen physician.” Dr. Traci Hurley joins us to share their story.

In this episode of Medsider Radio, we sat down with Todd Usen, CEO of Adagio Medical.Adagio specializes in catheter-based ablation technologies for the treatment of cardiac arrhythmias, with a focus on ventricular tachycardia (VT).  Todd has over three decades of leadership experience in the medical technology industry, with particular expertise in commercial strategy, operational performance, and business transformation. Before joining Adagio, Todd served as CEO of Minerva Surgical, a women's health company, and as CEO of Activ Surgical, a digital surgery startup. Todd has also served in executive positions at Olympus, United States Orthopedics, Smith and Nephew, and Boston Scientific.In this interview, Todd shares insights on making usability central to commercialization strategy, leveraging breakthrough designation beyond regulatory validation, and assembling effective boards by carefully selecting both investor and independent members who bring operational expertise.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Todd Usen.

Struggling with low payments and payer obstacles? In this episode, Brian Gallagher, PT, explains how to overcome the top reimbursement challenges in physical therapy and build a more profitable practice. Contact our team to take the next step.

In this episode, we deliver a critical update on the rapidly evolving legislative landscape impacting rheumatology. We explore the intense policy battles shaping the future of the field, including steep Medicare reimbursement cuts threatening the survival of many practices. We also examine the ongoing challenges posed by pharmacy benefit managers (PBMs) and the growing uncertainty around research funding. Joining us is a special guest, Lennie Shewmaker McDaniel, JD, who brings a firsthand perspective from Capitol Hill, shedding light on what it truly takes to advocate for our patients and the profession in today's complex policy environment.